MAKO Sets IPO Terms

MAKO Surgical Corp., a Ft. Lauderdale, Fla.-based developer of robotic solutions and implants for minimally-invasive orthopedic knee procedures, has set its IPO terms to 5.1 million common shares being offered at between $14 and $16 per share. It plans to trade on the Nasdaq under ticker symbol MAKO, with JPMorgan and Morgan Stanley serving as co-lead underwriters.

MAKO had raised $50 million in total VC funding, including a $30 million round last year. Shareholders include MK Investment Co. (13.4% pre-IPO stake), MDS Health Ventures (12.68%), Tudor Ventures (11.12%), MDS Health Ventures (12.68%), Sycamore Ventures (10.54%) Appaloosa Ventures (6.84%), Highbridge Capital (6.02%) and Aperture Venture Partners (5.96%), Ziegler Meditech Equity Partners, Ivy Healthcare Capital and The Exxel Group.